Algert Global’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$636K Buy
+78,215
New +$672K 0.01% 938
2025
Q4
Sell
-1,011,945
Closed -$8.96M 1242
2025
Q3
$8.96M Sell
1,011,945
-58,194
-5% -$415K 0.15% 218
2025
Q2
$6.17M Buy
1,070,139
+111,647
+12% +$684K 0.13% 262
2025
Q1
$6.33M Buy
958,492
+74,789
+8% +$583K 0.16% 200
2024
Q4
$7.7M Buy
883,703
+611,427
+225% +$8.8M 0.18% 171
2024
Q3
$5.32M Buy
272,276
+11,493
+4% +$233K 0.14% 233
2024
Q2
$5.37M Sell
260,783
-18,787
-7% -$386K 0.18% 158
2024
Q1
$5.96M Sell
279,570
-53,880
-16% -$1.05M 0.23% 118
2023
Q4
$4.79M Sell
333,450
-31,574
-9% -$310K 0.19% 147
2023
Q3
$3.33M Buy
365,024
+177,959
+95% +$1.81M 0.16% 207
2023
Q2
$1.98M Buy
187,065
+54,510
+41% +$645K 0.09% 390
2023
Q1
$1.62M Sell
132,555
-29,361
-18% -$366K 0.08% 421
2022
Q4
$2.01M Sell
161,916
-21,200
-12% -$308K 0.11% 296
2022
Q3
$2.5M Buy
183,116
+70,999
+63% +$1.1M 0.15% 206
2022
Q2
$2.06M Buy
112,117
+20,680
+23% +$297K 0.15% 180
2022
Q1
$1.47M Buy
91,437
+54,132
+145% +$782K 0.1% 355
2021
Q4
$522K Sell
37,305
-7,280
-16% -$118K 0.07% 521
2021
Q3
$835K Buy
44,585
+11,983
+37% +$226K 0.11% 321
2021
Q2
$680K Sell
32,602
-6,996
-18% -$174K 0.23% 143
2021
Q1
$1.12M Sell
39,598
-37,150
-48% -$1.18M 0.36% 96
2020
Q4
$2.51M Buy
76,748
+28,059
+58% +$986K 0.71% 22
2020
Q3
$1.49M Sell
48,689
-24,857
-34% -$549K 0.47% 66
2020
Q2
$1.2M Sell
73,546
-8,171
-10% -$118K 0.41% 78
2020
Q1
$813K Buy
81,717
+52,800
+183% +$604K 0.34% 111
2019
Q4
$398K Buy
+28,917
New +$428K 0.12% 230

Other funds holding KURA